CEO Alan White Commented:
“Over the last 3 years we have had continuous growth. 2016, however, marked the largest growth and improvement challenges we set ourselves and we are pleased to announce that at almost half way through the year, we are still on track. Whilst we appreciate there is some way to go, it is clear already that the trajectory of the business this year is even more positive than perhaps even we had anticipated.
On the financial side, it is clear that the continued development and growth of our local Pharmacovigilance and Regulatory Affairs vendor network, which we believe is probably the strongest of any global service provider, has made a real difference to bottom line. Clients have recognised the lengths to which we have gone in order to develop and manage this and now we are starting to see the result.
On the non-financial side, it is clear that our processes are robust enough now to enable us to grow in an efficient manner. Because we have implemented an ISO 9001-based QMS (Quality Management System) it is logical that we should get that certified, which we will in Q3 of 2016 by TUV of Germany”.